The total number of 10% top-cited scientific publications in endocrinology, diabetes, and metabolism in China is forecasted to rise significantly from 371.55 in 2024 to 591.76 in 2028. This indicates a yearly average growth (CAGR) over five years. This growth reflects an upward trend from the approximately 316 publications in 2023 based on linear extrapolation.

Future trends to watch for include:

Increased investments in research and development may further accelerate the number of top-cited publications.
The impact of international collaborations, which may enhance the citation impact of Chinese research.
The evolving clinical landscape in China, which can drive research innovation in these fields.